Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 44: 2399-2400, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lo, Y. M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lo, Y. M. D.
(Clinical Chemistry. 1998;44:2399-2400.)
© 1998 American Association for Clinical Chemistry, Inc.


Editorial

Quantitative Assays for Telomerase: Means for Studying the End

Y. M. Dennis Lo

Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories Hong Kong Special Administrative Region, Fax 852 2194 6171, E-mail loym@cuhk.edu.hk

The ends of human chromosomes consist of several kilobases of simple telomeric repeats (TTAGGG)n (1). Telomeres are important for maintaining chromosome structure by protecting the chromosomes from DNA degradation, end-to-end fusions, rearrangements, and chromosome loss. Because DNA polymerases synthesize DNA in the 5' to 3' direction and require an RNA primer for initiation, telomeric DNA may be lost at chromosome ends after cell division unless the termini are specifically extended by an alternative mechanism. This loss of telomeric DNA has been postulated to be one of the bases of cellular and possibly organismal senescence (1). The known mechanism for preventing this loss of telomeric DNA is based on a ribonucleoprotein polymerase called telomerase, which contains an integral RNA with a short template element that directs the synthesis of telomeric repeats at chromosome ends (2).

In humans, telomerase activity is present in the germ line but is not detected in many nondiseased adult tissues (3). In contrast to nondiseased tissues, telomerase activity is found in many human tumors (4). It is thought that the reactivation of telomerase activity, which maintains telomere length, plays an important role in the immortalization of cancer cells. Thus, considerable interest is focused on . . . [Full Text of this Article]


References




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
J. B. de Kok, T. J.M. Ruers, G. N.P. van Muijen, A. van Bokhoven, H. L. Willems, and D. W. Swinkels
Real-Time Quantification of Human Telomerase Reverse Transcriptase mRNA in Tumors and Healthy Tissues
Clin. Chem., March 1, 2000; 46(3): 313 - 318.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. Bièche, C. Noguès, V. Paradis, M. Olivi, P. Bedossa, R. Lidereau, and M. Vidaud
Quantitation of hTERT Gene Expression in Sporadic Breast Tumors with a Real-Time Reverse Transcription-Polymerase Chain Reaction Assay
Clin. Cancer Res., February 1, 2000; 6(2): 452 - 459.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.